Clinical trial

Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone)

NCT00006489 · University of Pennsylvania, Other · Completed

Key facts

NCT number NCT00006489
Title Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone)
Official title Naltrexone and Cognitive-Behavioral Therapy for Patients With Alcoholism and Post-Traumatic Stress Disorder
Lead sponsor University of Pennsylvania, Other
Collaborators National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH
Status Completed
Phase Phase 4
Study type Interventional
Conditions Alcoholism, Alcohol Dependence, Post-Traumatic Stress Disorder
Intervention type Behavioral, Drug
Interventions Cognitive-Behavioral Therapy, Naltrexone, Placebo
Enrollment 165
Start date Dec 1, 2000
Primary completion Feb 1, 2011
Completion Feb 1, 2011
First posted Nov 9, 2000
Last update posted Apr 21, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies